Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Paris

Showing results (371-380 of 383) with videos related to

Pageof 39
Sort By:
Plos One|November 19, 2010
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidateJeffrey R Currier, Viseth Ngauy, Mark S de Souza, et al.
Prehospital Emergency Care|July 12, 2002
Law Enforcement Agency Defibrillation (LEA-D): proceedings of the National Center for Early Defibrillation Police AED Issues ForumVincent N Mosesso, Mary M Newman, Joseph P Ornato, et al.
Prehospital Emergency Care|July 12, 2002
Law Enforcement Agency Defibrillation (LEA-D): position statement and best practices recommendations from the National Center for Early DefibrillationMary M Newman, Vincent N Mosesso, Joseph P Ornato, et al.
Amino Acids|July 10, 1999
Some of the amino acid chemistry going on in the Laboratory of Amino Acids, Peptides and ProteinsS Bouifraden, C Drouot, M el Hadrami, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2015
Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokineticsChau Vuong, Lisa H Xie, Brittney M J Potter, et al.
Physical Review Letters|July 30, 2016
Using Inertial Fusion Implosions to Measure the T+^{3}He Fusion Cross Section at Nucleosynthesis-Relevant EnergiesA B Zylstra, H W Herrmann, M Gatu Johnson, et al.
AIDS Research and Human Retroviruses|August 4, 2015
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine RegimensNicos Karasavvas, Chitraporn Karnasuta, Hathairat Savadsuk, et al.
Nature Medicine|September 1, 2015
HIV-1 infections with multiple founders are associated with higher viral loads than infections with single foundersHolly Janes, Joshua T Herbeck, Sodsai Tovanabutra, et al.
The Journal of Infectious Diseases|July 28, 2012
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/ESupachai Rerks-Ngarm, Robert M Paris, Supamit Chunsutthiwat, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Differential CYP 2D6 metabolism alters primaquine pharmacokineticsBrittney M J Potter, Lisa H Xie, Chau Vuong, et al.
Pageof 39

Showing results (371-380 of 383) with videos related to

Sort By:
Pageof 39
Plos One|November 19, 2010
Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidateJeffrey R Currier, Viseth Ngauy, Mark S de Souza, et al.
Prehospital Emergency Care|July 12, 2002
Law Enforcement Agency Defibrillation (LEA-D): proceedings of the National Center for Early Defibrillation Police AED Issues ForumVincent N Mosesso, Mary M Newman, Joseph P Ornato, et al.
Prehospital Emergency Care|July 12, 2002
Law Enforcement Agency Defibrillation (LEA-D): position statement and best practices recommendations from the National Center for Early DefibrillationMary M Newman, Vincent N Mosesso, Joseph P Ornato, et al.
Amino Acids|July 10, 1999
Some of the amino acid chemistry going on in the Laboratory of Amino Acids, Peptides and ProteinsS Bouifraden, C Drouot, M el Hadrami, et al.
Antimicrobial Agents and Chemotherapy|April 15, 2015
Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokineticsChau Vuong, Lisa H Xie, Brittney M J Potter, et al.
Physical Review Letters|July 30, 2016
Using Inertial Fusion Implosions to Measure the T+^{3}He Fusion Cross Section at Nucleosynthesis-Relevant EnergiesA B Zylstra, H W Herrmann, M Gatu Johnson, et al.
AIDS Research and Human Retroviruses|August 4, 2015
IgG Antibody Responses to Recombinant gp120 Proteins, gp70V1/V2 Scaffolds, and a CyclicV2 Peptide in Thai Phase I/II Vaccine Trials Using Different Vaccine RegimensNicos Karasavvas, Chitraporn Karnasuta, Hathairat Savadsuk, et al.
Nature Medicine|September 1, 2015
HIV-1 infections with multiple founders are associated with higher viral loads than infections with single foundersHolly Janes, Joshua T Herbeck, Sodsai Tovanabutra, et al.
The Journal of Infectious Diseases|July 28, 2012
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/ESupachai Rerks-Ngarm, Robert M Paris, Supamit Chunsutthiwat, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Differential CYP 2D6 metabolism alters primaquine pharmacokineticsBrittney M J Potter, Lisa H Xie, Chau Vuong, et al.
Pageof 39